Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N V Jacobus

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Diagnostic Microbiology and Infectious Disease|April 1, 1986
Activity of cefotetan against anaerobic bacteriaM B Dias, N V Jacobus, F P Tally, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2000
Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of bacteroides fragilis group: effect of the medium on test resultsD R Snydman, N V Jacobus, L A McDermott, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1995
Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclinesW J Weiss, N V Jacobus, P J Petersen, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1975
In vitro activity of penicillins against anaerobesF P Tally, N V Jacobus, J G Bartlett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1993
Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactamN V Jacobus, F W Immermann, J M Gupte, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1991
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase IP J Petersen, N V Jacobus, W J Weiss, et al.
International Journal of Antimicrobial Agents|May 1, 1996
In vitro activity of piperacillin/tazobactam against isolates from patients enrolled in clinical trialsN A Kuck, N V Jacobus, M D Spengler, et al.
Infection and Immunity|April 1, 1977
Superoxide dismutase in anaerobic bacteria of clinical significanceF P Tally, B R Goldin, N V Jacobus, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1976
Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteriaE C Ernst, S Berger, M Barza, et al.
The Annals of Otology, Rhinology & Laryngology. Supplement|September 1, 1991
Microbiology and antibiotic resistance in odontogenic infectionsS L Gorbach, W C Gilmore, N V Jacobus, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Diagnostic Microbiology and Infectious Disease|April 1, 1986
Activity of cefotetan against anaerobic bacteriaM B Dias, N V Jacobus, F P Tally, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2000
Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of bacteroides fragilis group: effect of the medium on test resultsD R Snydman, N V Jacobus, L A McDermott, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1995
Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclinesW J Weiss, N V Jacobus, P J Petersen, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1975
In vitro activity of penicillins against anaerobesF P Tally, N V Jacobus, J G Bartlett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1993
Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactamN V Jacobus, F W Immermann, J M Gupte, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1991
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase IP J Petersen, N V Jacobus, W J Weiss, et al.
International Journal of Antimicrobial Agents|May 1, 1996
In vitro activity of piperacillin/tazobactam against isolates from patients enrolled in clinical trialsN A Kuck, N V Jacobus, M D Spengler, et al.
Infection and Immunity|April 1, 1977
Superoxide dismutase in anaerobic bacteria of clinical significanceF P Tally, B R Goldin, N V Jacobus, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1976
Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteriaE C Ernst, S Berger, M Barza, et al.
The Annals of Otology, Rhinology & Laryngology. Supplement|September 1, 1991
Microbiology and antibiotic resistance in odontogenic infectionsS L Gorbach, W C Gilmore, N V Jacobus, et al.
Pageof 7